2016 annual financial data
Seres Therapeutics, Inc. 2016 Operating margin
Seres Therapeutics, Inc. 2016 operating margin with verified reported values.
Direct answer
Operating margin was -426.53%.
Operating income was -92,839,000 USD and net income was -91,579,000 USD.
Operating cash flow was 43,921,000 USD.
Get free Seres Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 21,766,000 USD
- Operating income
- -92,839,000 USD
- Net income
- -91,579,000 USD
- Operating cash flow
- 43,921,000 USD